Prostate specific antigen. A "has been" marker?;L'antigène spécifique de la prostate (PSA): Un marqueur tumoral en fin de règne

Medecine et Hygiene

Volumn 61, Issue 2461, 2003, Pages 2377-2381

  Deperthes, David ^a   Gygi, Christian M ^a   Jichlinski, Patrice ^a   Leisinger, Hans Jürg ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

CANCER SCREENING; EARLY DIAGNOSIS; PATHOPHYSIOLOGY; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 0346252237     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Lundwall A, Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Letters 1987; 214:317-22.
2. Hara M, Koyanagi Y, Inoue T, Fukuyama T. Some physico-chemical cheracteristics of «seminoprotein» an antigenic component specific for human seminal plasma. Jpn J Legal Med 1971;25:322-4.
3. Suominen J. The purification and new properties of the neutral proteinase in human semen. Int J. Fertil 1974;19:121-8.
4. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979; 17:159-63.
5. Werle E. Zur kenntis des haushalts des kallikreins. Biochem Z 1934; 269:415-39.
6. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985; 1899-903.
7. Deperthes D, Frenette G, Brillard-Bourdet M, et al. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J Androl 1996;17:659-65.
8. Rehault S, Monget P, Mazerbourg S, et al. Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. Eur J Biochem 2001; 268: 2960-8.
9. Heidtmann HH, Nettelbeck DM, Mingels A, et al. Generation of angio-statin-like fragments from plasminogen by prostate-specific antigen. Br J Cancer 1999; 81:1269-73.
10. Frenette G, Gervais Y, Tremblay RR, Dube JY. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J Urol 1998; 59: 13758.
11. Gutman AB. The development of the acid phosphatase test for prostatic carcinoma: The Sixth Ferdinand C. Valentine Memorial Lecture. Bull N Y Acad Med 1968; 44: 63-76.
12. Papsidero LD, Wang MC, Valenzuela L, et al, A prostate antigen in sera of prostatic cancer patients. Cancer Res 1980; 40: 2428-32.
13. Stamey TA, Yang N, Hay AR, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-16.
14. Schifman RB, Ahmann FR, Elvick A, et al. Analytical and physiotogical characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared. Clin Chem 1987;33: 2086-8.
15. Oesterling JE. Prostate specific antigen: A critical assessment of the most useful tumor marker for adeno-carcinoma of the prostate. J Urol 1991; 145: 907-23.
16. Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989; 142: 1011-7.
17. Stenman UH, Leinonen J, Alfthan H, et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51:222-6.
18. Carter HB, Morrell CH, Pearson JD, et al. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res 1992; 52: 3323-8.
19. Schmid HP, McNeal JE, Stamey TA. Clinical observations on the doubling time of prostate cancer. Eur Urol 1993: 23 (Suppl. 2): 60-3.
20. Deperthes D. Chapdelaine P, Tremblay RR. et al. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim Biophys Acta 1995: 1245: 311-6.
21. Tremblay RR. Deperthes D. Tetu B. Dube JY. Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors. Am J Pathol 1997: 150: 455-9.
22. Darson MF. Pacelli A. Roche P. et al. Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases. Urology 1999:53:939-44.
23. Haese A. Graefen M. Becker C. Noldus J. et al. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer. Prostate 2003: 54: 181-6.
24. Recker F. Kwiatkowski MK Piironen T. et al. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific. Urology 2000:55:481-5.
25. Diamandis EP. Okui A. Mitsui S. et al. Human kallikrein 11: A new biomarker of prostate and ovarian carcinoma. Cancer Res 2002: 62: 295-300.
26. Yousef GM. Stephan C. Scorilas A. et al. Differential expression of the human kallikrein gene 14 (KLK.14) in normal and cancerous prostatic tissues. Prostate 2003: 56: 287-92.
27. Stephan C, Yousef GM. Scorilas A. et al. Quantitative analysis of kallikrein 15 gene expression in prostate tissue. J Urol 2003: 169: 361-4.